Pipette tips for delivery to the health trusts in Helse Vest RHF

Description

The contracting authority wants tenders for pipette tips to be used at the laboratories in Helse Vest RHF [the Western Norway Regional Health Authority]. As a minimum, the tips must be able to be used for pipetting of various materials for analysis (such as biological sample materials, reagents, etc.). Lot 1: The contracting authority wants tenders for pipette tips to be used at the laboratories in Helse Vest RHF [the Western Norway Regional Health Authority]. As a minimum, the tips must be able to be used for pipetting of various materials for analysis (such as biological sample materials, reagents, etc.). We refer to Annex 1 - Price Form and Annex 2 - Requirement Specifications for more detailed information about what will be procured and which requirements are set for the requested pipette tips. The estimated contract value in Annex 1 - Price Form is based on information from previous consumption, and estimated consumption per year at the time of the notice. However, it is difficult to provide exact figures due to uncertainty connected to factors which will effect the request (such as disease/illness affecting the population). Based on this, the framework agreement will be valid for up to a 50% increase of the estimated value. Lot 1: The contracting authority wants tenders for pipette tips to be used at the laboratories in Helse Vest RHF [the Western Norway Regional Health Authority]. As a minimum, the tips must be able to be used for pipetting of various materials for analysis (such as biological sample materials, reagents, etc.). We refer to Annex 1 - Price Form and Annex 2 - Requirement Specifications for more detailed information about what will be procured and which requirements are set for the requested pipette tips. The estimated contract value in Annex 1 - Price Form is based on information from previous consumption, and estimated consumption per year at the time of the notice. However, it is difficult to provide exact figures due to uncertainty connected to factors which will effect the request (such as disease/illness affecting the population). Based on this, the framework agreement will be valid for up to a 50% increase of the estimated value.